voriconazole has been researched along with Opportunistic Infections in 105 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.95) | 18.2507 |
| 2000's | 43 (40.95) | 29.6817 |
| 2010's | 52 (49.52) | 24.3611 |
| 2020's | 9 (8.57) | 2.80 |
| Authors | Studies |
|---|---|
| Bouza, E; Guinea, J; Peláez, T; Recio, S; Torres-Narbona, M | 1 |
| Fille, M; Hausdorfer, J; Hinterberger, G; Lass-Flörl, C; Mayr, A; Perkhofer, S; Speth, C | 1 |
| Inamine, T; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Miyazaki, Y; Nagayoshi, Y; Saijo, T; Seki, M; Yamamoto, Y; Yamauchi, S; Yanagihara, K | 1 |
| Chen, J; Shen, X; Tang, G; Yan, K; Yan, L; Yao, H; Yuan, X | 1 |
| Calvo, C; Gavalda, M; Gimenez, S; Lorenzo, A; Martin, L; Riera, M; Vilchez, H | 1 |
| Barbieri, S; Becchetti, C; Burra, P; Cattelan, A; Cillo, U; Feltracco, P; Ferrarese, A; Germani, G; Saluzzo, F; Senzolo, M | 1 |
| Beswick, DM; Detwiller, K; Krane, NA; Sauer, D; Shindo, M | 1 |
| Guarro, J; Pérez-Cantero, A | 1 |
| Angarone, M; Flaherty, JD; Mylvaganam, R; Peigh, G; Quaggin-Smith, J; Witting, C | 1 |
| Bhagali, R; Prabhudesai, MN; Prabhudesai, NP | 1 |
| Ai, L; Chen, Y; Huang, J; Liang, Y; Tang, W; Zhao, Y; Zhou, Y | 1 |
| Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA; Rhomberg, PR | 1 |
| Bassetti, M; Bouza, E | 1 |
| Aleshin, M; Borok, J; Sarantopoulos, G; Worswick, S | 1 |
| Baker, CJ; Brackett, J; Edwards, MS; Foster, CE; Healy, CM; Schady, DA | 1 |
| Ahangarkani, F; Aslani, N; Badali, H; Boekhout, T; Hagen, F; Kolecka, A; Meis, JF; Meyabadi, MF; Shokohi, T | 1 |
| Chang, YC; Graf, E; Green, AM | 1 |
| Chen, TW; Chiu, YC; Fan, HL; Ho, MH; Hsieh, CB | 1 |
| Bacci, F; Bertuzzi, C; Bonifazi, F; Cavo, M; Cricca, M; De Cicco, G; Lewis, RE; Paolini, S; Sassi, C; Stanzani, M; Sutto, E | 1 |
| Chen, H; Hu, J; Hu, L; Jiang, M; Li, B; Li, Y; Lou, X; Ning, H; Wang, J; Xu, C; Yu, Z | 1 |
| Arıkan Akdağlı, S; Aydeniz Ozansoy, F; Dursunoğlu, N; Ergin, C; Kutlu, M; Sarı, I; Sarıbaş, Z | 1 |
| Bobek-Billewicz, B; Foroncewicz, B; Jarząb, B; Krawczyk, M; Mucha, K; Orłowski, T; Pączek, L; Raczyńska, J; Religioni, J | 1 |
| Aline-Fardin, A; Buot, G; Dannaoui, E; Degulys, A; Guitard, J; Hennequin, C; Lapusan, S; Marie, JP; Rio, B | 1 |
| Bucknor, MD; Gross, AJ; Link, TM | 1 |
| Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Beckman, EN; Garces, JC; Garcia-Diaz, JB; Keller, RA; Loss, GE; Pankey, GA; Schieffelin, JS; Staffeld-Coit, C | 1 |
| Barutcu, E; Celik, AD; Pamuk, GE; Pamuk, ON | 1 |
| Faria-Ramos, I; Miranda, IM; Pina-Vaz, C; Ricardo, E; Rodrigues, AG; Silva, RM | 1 |
| Bienvenu, AL; Boibieux, A; Cassier, P; Dananché, C; Gautheron, N; Nicolle, MC; Perraud, M; Sautour, M; Vanhems, P; Wegrzyn, J | 1 |
| Cassumbhoy, M; Chau, MM; Cooper, CM; Kong, DC; Marriott, DJ; Roberts, JA; Trubiano, JA; Urbancic, K; van Hal, SJ; Wilkes, J; Worth, LJ | 1 |
| Aoki, V; Barbaro Del Negro, GM; Benard, G; Buccheri de Oliveira, R; Duarte, A; Giuli Santi, C; Lopes Motta, A; Nobrega de Almeida Júnior, J; Rossi, F; Sachiko Yamamoto de Figueiredo, D; Wakisaka Maruta, C | 1 |
| Fong, PH; Lee, VH; Seneviratne, CJ; Wong, SS | 1 |
| Chang, SC; Ko, BS; Lee, SH; Sun, HY | 1 |
| Bhat, V; Devadas, SK; Khattry, N | 1 |
| Ahn, KS; Hwang, JS; Jang, BK; Kang, KJ; Kang, YN; Kim, HT; Kim, IM; Kim, TS; Kim, YH | 1 |
| Block, C; Moses, AE; Or, R; Shapira, MY; Strahilevitz, J; Tzadok, R | 1 |
| Baba, H; Baba, Y; Iwatsuki, M; Kurashige, J; Miyamoto, Y; Ohuchi, M; Sakamoto, Y; Shigaki, H; Tokunaga, R; Watanabe, M; Yoshida, N | 1 |
| Aala, F; Amirizad, K; Aslani, N; Badali, H; Hashemi, SJ; Khodavaisy, S; Nazeri, M; Nouripour-Sisakht, S; Rezaie, S; Sorkherizi, MS | 1 |
| Altınbas, R; Ilkit, M; Kiraz, N; Ozdemir, HG; Sav, H; Seyedmousavi, S | 1 |
| Takenaka, M | 1 |
| Kimura, S | 1 |
| Akyol, G; Atalay, A; Cakir, N; Kaynar, L; Koc, AN; Ulu-Kilic, A | 1 |
| Chung, SJ; Hwang, WY; Tan, AL; Tan, BH; Tan, TT; Thien, SY | 1 |
| Non, LR; Pande, A; Romee, R; Santos, CA | 1 |
| Akyürek, N; Aydın Kaynar, L; Aygencel, G; Güzel Tunçcan, Ö; Kalkancı, A; Özkurt, ZN; Ülküden, B | 1 |
| Ananda-Rajah, MR; Grigg, A; Slavin, MA | 1 |
| Fanci, R | 1 |
| Alp, S; Arikan, S; Hasçelik, G; Sancak, B | 1 |
| Karaahmet, T; Korten, V; Odabasi, Z; Tigen, E; Tigen, K | 1 |
| George, E; Shinohara, MM | 1 |
| Arendrup, MC; Krarup, E; Larsen, CG; Larsen, FG; Pedersen, M; Thybo, S | 1 |
| Kumar, P; Matsumoto, C; Pien, E; Rosen, J; Shanmugam, VK; Steen, V; Whelton, S | 1 |
| Amigues, I; Barker, J; Chung, D; Cohen, N; Jakubowski, A; Papanicolaou, GA; Plescia, C; Seo, SK | 1 |
| Furuya, A; Ida, K; Kato, M; Koh, K; Okamoto, T; Takita, J | 1 |
| Hariga, D; Khaled, S; Trabelsi, S | 1 |
| Bermudez, C; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A | 1 |
| Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A | 1 |
| Ayub, A; Kenney, CV; McKiernan, FE | 1 |
| Kuithan, F; Scheer, F; Wiggermann, P | 1 |
| Chang, FY; Ho, SJ; Lin, JC; Shang, ST; Wang, NC; Yang, YS | 1 |
| Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC | 1 |
| Chugh, TD; Duggal, S; Jain, H; Sharma, A; Tyagi, A | 1 |
| Bergstresser, P; Chan, J; Dai, W; Dharamsi, JW; Gander, R; Ricotti, C; Soliman, S | 1 |
| Miller, CJ; Seykora, JT; Shinohara, MM | 1 |
| Choi, SM; Kang, MK; Kim, HJ; Kim, SH; Kwon, JC; Lee, DG; Min, WS | 1 |
| Andrés, R; Elías, T; Fernandez de Orueta, L; Pintado, V | 1 |
| Babor, F; Borkhardt, A; Janßen, G; Laws, HJ; Mackenzie, C; Meisel, R; Sabir, H; Schaper, J; Schuster, F; Siepermann, M; Wessalowski, R | 1 |
| Brokalaki, EI; Hillen, U; Sommerwerck, U; von Heinegg, EH | 1 |
| Bennett, D; Endo, J; Kleker, B; Snow, S | 1 |
| Baršić, B; Mlinarić Missoni, E | 1 |
| Howden, BP; Mijch, AM; Schwarer, AP; Slavin, MA | 1 |
| Anghilieri, M; Cafro, AM; Carrafiello, G; Cesana, C; D'Avanzo, G; Marbello, L; Morra, E; Nosari, A | 1 |
| Cook, C; Fernandez, C; Fraser, R; McCully, B; Schmidt, M; Shouldice, E | 1 |
| Klopfenstein, KJ; Powell, D; Rosselet, R; Termuhlen, A | 1 |
| Gallamini, A; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Pugno, F; Viscoli, C | 1 |
| Martin, PL; Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ | 1 |
| Innes, JR; Moss, PJ; Thaker, HR; Varma, D; Wedgwood, K | 1 |
| Rubin, ZA; Somani, J | 1 |
| Friedrich, W; Gahr, M; Hahn, G; Koch, A; Roesler, J; Rösen-Wolff, A | 1 |
| Alkan, Y; Burhenne, J; Haefeli, WE; Shalit, I; Stein, J; Yaniv, I | 1 |
| Boeckh, M; Carter, RA; Corey, L; Kim, HW; Marr, KA | 1 |
| Viscoli, C | 1 |
| Chadwick, EG; Guzman-Cottrill, JA; Zheng, X | 1 |
| Beltramo, D; Levin, T; Samuel, R; Suh, B | 1 |
| Jagirdar, J; Scott, RS; Sutton, DA | 1 |
| Bonatti, H; Dierich, MP; Freund, M; Gastl, G; Griff, K; Kropshofer, G; Lass-Flörl, C; Mayr, A; Nachbaur, D; Petzer, A | 1 |
| Colombo, GL; Morlotti, L; Serra, G | 1 |
| Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Delikou, S; Kitra, V; Miyakis, S; Papadakis, V; Papadatos, I; Parcharidou, A; Polychronopoulou, S; Velegraki, A | 1 |
| Axer-Siegel, R; Bishara, J; Blau, H; Kramer, M; Kramer, MR; Weinberger, D | 1 |
| Arechavala, A; Bianchi, MH; López Daneri, G; Negroni, R; Robles, AM; Santiso, G | 1 |
| Cornely, OA; Glöckner, A | 1 |
| Akiyama, H; Honma, M; Ito, T; Muramatsu, T; Negishi, K; Ohashi, K; Sakai, M; Sakamaki, H; Shitara, M; Suzuki, T; Ueki, T; Yamashita, T | 1 |
| Honda, M; Ichiyasu, H; Kohrogi, H; Matsumoto, M; Okamoto, S; Okamoto, T; Sato, K; Tsumori, K; Yamamura, A | 1 |
| Kontoyiannis, DP; Lewis, RE | 1 |
| Jarque, I; Sanz, MA | 1 |
| Guarro, J; Pastor, FJ | 1 |
| Feldberg, E; Halperin, D; Lahav, J; Warman, M | 1 |
| Denning, DW; Pasqualotto, AC; Shah, M; Wynn, R | 1 |
| Bourolias, CA; Karatzanis, AD; Kofteridis, DP; Mantadakis, E; Papazoglou, G; Samonis, G; Velegrakis, GA | 1 |
| Mavinkurve-Groothuis, AM; van Die, LE; van't Hek, LG; Verweij, PE; Warris, A; Zwitserloot, AM | 1 |
| Milatovic, D; Schwartz, S; Thiel, E | 1 |
| Chiou, CC; Groll, AH; Walsh, TJ | 1 |
| Arnadóttir, M; Asmundsson, P; Bödvarsson, M; Hilmarsdóttir, I; Thorsteinsson, SB | 1 |
| Espinel-Ingroff, A | 1 |
23 review(s) available for voriconazole and Opportunistic Infections
| Article | Year |
|---|---|
Geotrichum capitatum Invasive Infection Early After Liver Transplant.
Topics: Amphotericin B; Antifungal Agents; Fatal Outcome; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Fungal Infections; Liver Transplantation; Male; Middle Aged; Multiple Organ Failure; Opportunistic Infections; Saccharomycetales; Sepsis; Treatment Outcome; Voriconazole | 2020 |
Sarocladium and Acremonium infections: New faces of an old opportunistic fungus.
Topics: Acremonium; Animals; Antifungal Agents; Arthritis; Blood; Central Nervous System Infections; Dermatomycoses; Drug Resistance, Fungal; Endocarditis; Eye Infections; Humans; Hypocreales; Invasive Fungal Infections; Mycetoma; Mycoses; Onychomycosis; Opportunistic Infections; Osteomyelitis; Peritonitis; Respiratory Tract Infections; Voriconazole | 2020 |
Invasive mould infections in the ICU setting: complexities and solutions.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Critical Illness; Galactose; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Lung Diseases, Fungal; Mannans; Mucor; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory System; Triazoles; Voriconazole | 2017 |
Trichosporonosis in Pediatric Patients With a Hematologic Disorder.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Lipopeptides; Male; Micafungin; Neutropenia; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trichosporonosis; Voriconazole | 2018 |
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature.
Topics: Adult; Aged; Antifungal Agents; Disease Outbreaks; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Saccharomycetales; Voriconazole | 2019 |
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2014 |
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.
Topics: Antifungal Agents; Consensus; Drug Administration Schedule; Drug Delivery Systems; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Hematologic Neoplasms; Humans; Molecular Sequence Data; Mycoses; Opportunistic Infections; Practice Guidelines as Topic; Rehydration Solutions; Triazoles; Voriconazole | 2014 |
A Case of Cutaneous Fusariosis of the Scrotum as a Complication of Acute Myeloid Leukemia.
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Fusariosis; Fusarium; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Scrotum; Skin; Voriconazole | 2016 |
Invasive Aspergillosis in Hematological Patients.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Biomarkers; Echinocandins; Hematologic Neoplasms; Humans; Neutropenia; Opportunistic Infections; Risk Factors; Stem Cell Transplantation; Tomography, X-Ray Computed; Voriconazole | 2016 |
Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cryptococcus; Cytarabine; Dermatomycoses; Echinocandins; Exanthema; Fever; Fungemia; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipopeptides; Male; Micafungin; Opportunistic Infections; Retrospective Studies; Saccharomyces; Salvage Therapy; Trichosporon; Ustilaginales; Vidarabine; Voriconazole; Yeasts | 2017 |
First case of Trichoderma longibrachiatum infection in a renal transplant recipient in Tunisia and review of the literature.
Topics: Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Trichoderma; Tunisia; Voriconazole | 2010 |
The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review.
Topics: Aged; Antifungal Agents; Diabetes Mellitus, Type 2; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Risk Factors; Saccharomycetales; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Rhodotorula fungemia: two cases and a brief review.
Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Female; Fungemia; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Pyrimidines; Rhodotorula; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries | 2011 |
Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.
Topics: Antifungal Agents; Caspofungin; Child; Echinocandins; Fatal Outcome; Humans; Immunocompromised Host; Lipopeptides; Male; Mitosporic Fungi; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2004 |
New options for the treatment of invasive fungal infections.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Endocarditis; Female; Follow-Up Studies; Fungemia; Fusarium; Humans; Immunocompromised Host; Infant; Leukemia, Myeloid, Acute; Liposomes; Opportunistic Infections; Pyrimidines; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Aspergillus mediastinitis following orthotopic heart transplantation: case report and review of the literature.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Administration Schedule; Heart Transplantation; Humans; Male; Mediastinitis; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2004 |
Voriconazole versus amphotericin B in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Invasive Acremonium strictum infection in a bone marrow transplant recipient.
Topics: Acremonium; Antifungal Agents; Bone Marrow Transplantation; Child; Female; Humans; Male; Mycoses; Opportunistic Infections; Osteomyelitis; Pyrimidines; Tibia; Triazoles; Urine; Voriconazole | 2006 |
[Zygomycosis after hematogeneic stem cell transplantation--a current problem?].
Topics: Aspergillosis; Cancer Care Facilities; Cross Infection; Cross-Sectional Studies; Germany; Hematopoietic Stem Cell Transplantation; Humans; Long-Term Care; Opportunistic Infections; Pyrimidines; Risk Factors; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis | 2006 |
[Current indications for voriconazole in onco-hematological patients].
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Drug Resistance, Fungal; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Salvage Therapy; Spain; Triazoles; Voriconazole; Zygomycosis | 2007 |
[The role of voriconazole in the treatment of emerging mycoses].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Communicable Diseases, Emerging; Fusarium; Humans; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2007 |
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer.
Topics: Anidulafungin; Antifungal Agents; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neoplasms; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2000 |
1 trial(s) available for voriconazole and Opportunistic Infections
| Article | Year |
|---|---|
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2011 |
81 other study(ies) available for voriconazole and Opportunistic Infections
| Article | Year |
|---|---|
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
Topics: Antifungal Agents; Aspergillus; Candida; Fluconazole; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2008 |
Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Europe; Fungi; Guidelines as Topic; Humans; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Triazoles; Yeasts | 2008 |
Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
Topics: Animals; Antifungal Agents; Base Sequence; Calcineurin; Candida glabrata; Candidiasis; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Female; Fungal Proteins; Genes, Fungal; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation; Opportunistic Infections; Transcription Factors; Virulence | 2010 |
Palatal perforation caused by Alternaria alternata infection in an immunocompetent adolescent.
Topics: Adolescent; Alternaria; Biopsy; Humans; Male; Mycoses; Opportunistic Infections; Voriconazole | 2023 |
Skin lesions by Scedosporium apiospermum and Nocardia pulmonary infection in an oncologic patient: a case report.
Topics: Aged; Antifungal Agents; Humans; Immunocompromised Host; Nocardia; Nocardia Infections; Opportunistic Infections; Pneumonia; Scedosporium; Skin Diseases; Voriconazole | 2023 |
Allergic Fungal Sinusitis Imitating an Aggressive Skull Base Lesion in the Setting of Pembrolizumab Immunotherapy.
Topics: Abducens Nerve Diseases; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antineoplastic Agents, Immunological; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Headache; Humans; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Opportunistic Infections; Sinusitis; Skin Neoplasms; Skull Base Neoplasms; Tomography, X-Ray Computed; Voriconazole | 2021 |
Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antiviral Agents; Aspergillus; COVID-19 Drug Treatment; Humans; Immunomodulation; Invasive Pulmonary Aspergillosis; Male; Micafungin; Opportunistic Infections; Receptors, Interleukin-6; SARS-CoV-2; Voriconazole | 2021 |
Post COVID-19 opportunistic candida retinitis: A case report.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; COVID-19; Eye Infections, Fungal; Fluconazole; Humans; Intravitreal Injections; Male; Opportunistic Infections; Retinitis; SARS-CoV-2; Tomography, Optical Coherence; Visual Acuity; Voriconazole | 2021 |
Rapid and precise diagnosis of pneumonia coinfected by Pneumocystis jirovecii and Aspergillus fumigatus assisted by next-generation sequencing in a patient with systemic lupus erythematosus: a case report.
Topics: Adolescent; Aspergillus fumigatus; Caspofungin; Coinfection; Female; High-Throughput Nucleotide Sequencing; Humans; Lupus Erythematosus, Systemic; Opportunistic Infections; Pneumocystis carinii; Pneumonia; Sulfamethoxazole; Trimethoprim; Voriconazole | 2021 |
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Europe; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; North America; Opportunistic Infections; Triazoles; Voriconazole | 2021 |
Image Gallery: Immunocompromised patient presenting with inguinal rash: a case of Scedosporium apiospermum.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Dermatomycoses; Dexamethasone; Drug Eruptions; Etoposide; Exanthema; Humans; Immunocompromised Host; Lymphohistiocytosis, Hemophagocytic; Lymphoma, B-Cell; Male; Opportunistic Infections; Scedosporium; Voriconazole | 2017 |
Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients.
Topics: Adolescent; Antifungal Agents; Candida; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; Fluconazole; Humans; Kluyveromyces; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Nitriles; Opportunistic Infections; Pichia; Pyridines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole | 2018 |
Invasive Curvularia Infection in Pediatric Patients With Hematologic Malignancy Identified by Fungal Sequencing.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Child; Dermatomycoses; Female; Humans; Immunocompromised Host; Male; Opportunistic Infections; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; RNA, Ribosomal, 28S; Sequence Analysis, DNA; Voriconazole | 2019 |
Twice-Weekly Tacrolimus Can Overcome Pharmacologic Interaction and Help in the Successful Treatment of Pulmonary Aspergillosis in a Liver Transplant Recipient.
Topics: Antifungal Agents; Calcineurin Inhibitors; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Graft Rejection; Graft Survival; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Opportunistic Infections; Pulmonary Aspergillosis; Tacrolimus; Treatment Outcome; Voriconazole | 2019 |
Dermatic Scedosporium apiospermum infection after autologous bone marrow transplantation.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Dermatomycoses; Drugs, Chinese Herbal; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Opportunistic Infections; Postoperative Complications; Pyrimidines; Scedosporium; Skin Ulcer; Transplantation Conditioning; Transplantation, Autologous; Triazoles; Voriconazole; Young Adult | 2013 |
[Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient].
Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Caspofungin; Echinocandins; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lung; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Atypical presentation of invasive pulmonary aspergillosis in a liver transplant recipient.
Topics: Adolescent; Antifungal Agents; Hepatoblastoma; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Liver Neoplasms; Liver Transplantation; Male; Opportunistic Infections; Pyrimidines; Solitary Pulmonary Nodule; Time Factors; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia.
Topics: Acremonium; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2014 |
Voriconazole-induced periostitis in two post-transplant patients.
Topics: Antifungal Agents; Female; Heart Transplantation; Humans; Male; Middle Aged; Opportunistic Infections; Periostitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Radionuclide Imaging; Radiopharmaceuticals; Stem Cell Transplantation; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Brain Abscess; Debridement; Female; Humans; Immunosuppression Therapy; Itraconazole; Lung Abscess; Male; Middle Aged; Opportunistic Infections; Organ Transplantation; Phaeohyphomycosis; Retrospective Studies; Time Factors; Voriconazole; Young Adult | 2014 |
The development of pulmonary aspergillosis and pneumothorax in a patient with neutropenic systemic lupus erythematosus and successful treatment of the first case.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillus fumigatus; Drainage; Female; Humans; Lupus Erythematosus, Systemic; Neutropenia; Opportunistic Infections; Pneumothorax; Prednisolone; Pulmonary Aspergillosis; Staphylococcal Infections; Staphylococcus aureus; Voriconazole; Young Adult | 2014 |
In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; ATP-Binding Cassette Transporters; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression; Humans; Male; Mutation; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sterol 14-Demethylase; Tacrolimus; Voriconazole | 2014 |
Fungaemia caused by Fusarium proliferatum in a patient without definite immunodeficiency.
Topics: Aged; Antifungal Agents; Arthroplasty, Replacement, Hip; Catheter-Related Infections; Central Venous Catheters; Female; France; Fusariosis; Fusarium; Humans; Microbial Sensitivity Tests; Opportunistic Infections; Voriconazole | 2015 |
Trichosporon inkin as an Emergent Pathogen in Patients With Severe Pemphigus.
Topics: Aged; Amphotericin B; Antifungal Agents; Child; Drug Resistance, Fungal; Fatal Outcome; Female; Humans; Male; Microbial Sensitivity Tests; Opportunistic Infections; Pemphigus; Severity of Illness Index; Trichosporon; Trichosporonosis; Voriconazole | 2015 |
Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Carcinoma; Caspofungin; Chemoradiotherapy; Chemotherapy, Adjuvant; Drug Resistance, Fungal; Echinocandins; Exophiala; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Lipopeptides; Male; Middle Aged; Mouth Diseases; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Opportunistic Infections; Phaeohyphomycosis; Radiotherapy, Intensity-Modulated; Voriconazole | 2015 |
Breakthrough invasive fungal infection under the use of posaconazole and voriconazole.
Topics: Antifungal Agents; Colletotrichum; Drug Resistance, Multiple, Fungal; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Opportunistic Infections; Triazoles; Voriconazole | 2016 |
Subcutaneous infection caused by Blastoschizomyces capitatus post allogeneic hematopoietic transplant and its successful treatment with voriconazole.
Topics: Adult; Antifungal Agents; Dermatomycoses; Dipodascus; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Voriconazole | 2015 |
Successful Treatment of Combined Aspergillus and Cytomegalovirus Abscess in Brain and Lung After Liver Transplant for Toxic Fulminant Hepatitis.
Topics: Antifungal Agents; Biopsy; Brain Abscess; Chemical and Drug Induced Liver Injury; Cytomegalovirus Infections; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Liver Transplantation; Lung Abscess; Magnetic Resonance Imaging; Middle Aged; Mushroom Poisoning; Neuroaspergillosis; Neurosurgical Procedures; Opportunistic Infections; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2017 |
Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Clinical Protocols; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Itraconazole; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pharmaceutical Solutions; Survival Rate; Transplantation, Homologous; Voriconazole; Young Adult | 2015 |
Orbital Apex Syndrome Caused by Invasive Aspergillosis as an Adverse Effect of Systemic Chemotherapy for Metastatic Colorectal Cancer: a Case Report.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Biopsy; Colorectal Neoplasms; Eye Pain; Humans; Immunocompromised Host; Liver Neoplasms; Magnetic Resonance Imaging; Male; Opportunistic Infections; Orbital Diseases; Syndrome; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2016 |
In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Environmental Microbiology; Humans; Iran; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Opportunistic Infections; Triazoles; Voriconazole | 2016 |
Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Drug Resistance, Fungal; Eye Diseases; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Natamycin; Opportunistic Infections; Peptide Hydrolases; Phospholipases; Virulence; Virulence Factors; Voriconazole | 2016 |
Pulmonary infection caused by Talaromyces purpurogenus in a patient with multiple myeloma.
Topics: Acinetobacter Infections; Aged; Antifungal Agents; Coinfection; Fatal Outcome; Female; Humans; Immunocompromised Host; Lung Diseases, Fungal; Multiple Myeloma; Opportunistic Infections; Plasmacytoma; Pulmonary Disease, Chronic Obstructive; Species Specificity; Spinal Neoplasms; Sputum; Talaromyces; Thoracic Vertebrae; Voriconazole | 2016 |
Recurrent trichosporonosis with central nervous system involvement in an allogeneic hematopoietic stem cell transplant recipient.
Topics: Anemia, Aplastic; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Central Nervous System; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrocephalus; Immunocompromised Host; Immunosuppression Therapy; Laminectomy; Lipopeptides; Magnetic Resonance Imaging; Opportunistic Infections; Recurrence; Transplantation, Autologous; Treatment Outcome; Triazoles; Trichosporon; Trichosporonosis; Ventriculoperitoneal Shunt; Voriconazole | 2016 |
[A rare and mortal infection agent in patients with hematological malignancies: Saprochaete capitata].
Topics: Adult; Amphotericin B; Animals; Antifungal Agents; Caspofungin; Catheter-Related Infections; Echinocandins; Fatal Outcome; Female; Fungemia; Humans; Leukemia; Lipopeptides; Moths; Mycoses; Opportunistic Infections; Saccharomycetales; Voriconazole; Young Adult | 2016 |
Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis.
Topics: Administration, Oral; Antifungal Agents; Antineoplastic Agents; Fatal Outcome; Humans; Leukemia; Male; Middle Aged; Mycetoma; Opportunistic Infections; Pyrimidines; Recurrence; Scedosporium; Triazoles; Voriconazole | 2008 |
Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Cross Infection; Echinocandins; Fungemia; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
[Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of Blastoschizomyces capitatus (Geotrichum capitatum) by two different methods].
Topics: Antifungal Agents; Dipodascus; Fluconazole; Geotrichosis; Humans; Itraconazole; Microbial Sensitivity Tests; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Concomitant Aspergillus and Cytomegalovirus infection in heart transplant: early diagnosis is the key to successful treatment.
Topics: Acute Disease; Antifungal Agents; Antiviral Agents; Cardiomyopathy, Dilated; Cytomegalovirus Infections; Early Diagnosis; Ganciclovir; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Opportunistic Infections; Pulse Therapy, Drug; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Scedosporium apiospermum: an emerging opportunistic pathogen that must be distinguished from Aspergillus and other hyalohyphomycetes.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Diagnosis, Differential; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycetoma; Opportunistic Infections; Pyrimidines; Scedosporium; Skin Diseases; Triazoles; Voriconazole | 2009 |
Subcutaneous phaeohyphomycosis in a renal transplant recipient successfully treated with voriconazole.
Topics: Adult; Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Voriconazole-associated myositis.
Topics: Acute Disease; Adult; Antifungal Agents; Aspergillosis; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Myositis; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Cohort Studies; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Liver; Liver Function Tests; Lymphocyte Depletion; Male; Opportunistic Infections; Pyrimidines; Retrospective Studies; Risk Factors; Statistics as Topic; T-Lymphocytes; Triazoles; Voriconazole | 2010 |
Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida tropicalis; Candidiasis; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Fungemia; Humans; Infant; Lipopeptides; Male; Micafungin; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
Topics: Adult; Aged; Antifungal Agents; Carcinoma, Squamous Cell; Case-Control Studies; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Multivariate Analysis; Mycoses; Opportunistic Infections; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Sunlight; Triazoles; Voriconazole | 2010 |
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2011 |
Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.
Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Opportunistic Infections; Periostitis; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Radiography; Radionuclide Imaging; Triazoles; Voriconazole | 2011 |
[Fatal outcome of invasive tracheal aspergillosis].
Topics: Antifungal Agents; Bronchi; Carotid Artery, External; Caspofungin; Contrast Media; Echinocandins; Fatal Outcome; Hemoptysis; Humans; Image Processing, Computer-Assisted; Iohexol; Lipopeptides; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, Spiral Computed; Trachea; Tracheal Diseases; Triazoles; Voriconazole; Young Adult | 2011 |
Cutaneous fusariosis developing in a post-irradiation site.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Debridement; Dermatomycoses; Female; Fusarium; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg Ulcer; Lymphoma, Non-Hodgkin; Opportunistic Infections; Postoperative Complications; Prednisone; Pyrimidines; Radiodermatitis; Radiotherapy; Skin Neoplasms; Triazoles; Voriconazole | 2011 |
Pigmented fruiting bodies and birefringent crystals in a surgical wound: A clue to Aspergillus niger infection.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus niger; Crystallization; Debridement; Fruiting Bodies, Fungal; Humans; Male; Opportunistic Infections; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole | 2011 |
A case of pseudomembranous colitis after voriconazole therapy.
Topics: Adult; Antifungal Agents; Enterocolitis, Pseudomembranous; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2011 |
[Vertebral aspergillosis in a cirrhotic patient: an uncommon cause of spondylitis].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biomarkers; Cross Infection; Fatal Outcome; Galactose; Haemophilus influenzae; Hepatitis C, Chronic; Humans; Immunocompromised Host; Liver Cirrhosis; Low Back Pain; Lumbar Vertebrae; Male; Mannans; Middle Aged; Multiple Organ Failure; Opportunistic Infections; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Spondylitis; Triazoles; Voriconazole | 2012 |
Invasive aspergillosis in pediatric oncology patients: a rare event with poor prognosis--case analysis to plan better targeted prophylactic or therapeutic measurement.
Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole | 2012 |
Ochroconis gallopavum infection in a lung transplant recipient: report of a case.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Biopsy; Bronchiolitis Obliterans; Disease Progression; Drug Administration Schedule; Enterobacter cloacae; Enterococcus; Fatal Outcome; Humans; Imipenem; Lung Transplantation; Male; Opportunistic Infections; Phaeohyphomycosis; Pyrimidines; Respiratory Tract Infections; Skin; Sputum; Tobramycin; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Mohs micrographic surgery for the treatment of localized cutaneous alternariosis.
Topics: Alternariosis; Antifungal Agents; Humans; Male; Middle Aged; Mohs Surgery; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2013 |
Two rare cases of central nervous system opportunistic mycoses.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus nidulans; Cryptococcus neoformans; Female; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Neuroaspergillosis; Opportunistic Infections; Pregnancy; Pregnancy Complications, Infectious; Rare Diseases; Treatment Outcome; Voriconazole | 2012 |
Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycetoma; Naphthalenes; Opportunistic Infections; Pyrimidines; Risk Assessment; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Successful treatment with voriconazole of cerebral aspergillosis in an hematologic patient.
Topics: Antifungal Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Neuroaspergillosis; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
Topics: Acute Disease; Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Female; Hepatitis; Humans; Leukemia; Lung Diseases, Fungal; Opportunistic Infections; Osteomyelitis; Pyrimidines; Remission Induction; Sacroiliac Joint; Splenic Diseases; Triazoles; Voriconazole | 2003 |
Successful treatment of Scedosporium pneumonia with voriconazole during AML therapy and bone marrow transplantation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Mycetoma; Opportunistic Infections; Pyrimidines; Risk Assessment; Scedosporium; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Successful treatment of Acremonium fungemia with voriconazole.
Topics: Acremonium; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Female; Fungemia; Humans; Lymphoma, Mantle-Cell; Middle Aged; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2003 |
Use of voriconazole in candida retinitis.
Topics: Adult; Antifungal Agents; Candidiasis; Eye Infections, Fungal; Fatal Outcome; Female; Humans; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2005 |
Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease.
Topics: Adolescent; Amphotericin B; Aspergillosis; Aspergillus nidulans; Caspofungin; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Granulomatous Disease, Chronic; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Risk Assessment; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect.
Topics: Adolescent; Antifungal Agents; Bradycardia; Female; Fusarium; Humans; Mycoses; Opportunistic Infections; Pyrimidines; Tachycardia, Ventricular; Torsades de Pointes; Triazoles; Voriconazole | 2004 |
Combination antifungal therapy for invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Combination therapy for invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Bone Marrow Transplantation; Drug Resistance, Fungal; Fungemia; Gastrointestinal Diseases; Graft vs Host Disease; Granuloma; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2005 |
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Austria; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Genes, Fungal; Hematologic Neoplasms; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Organ Transplantation; Peptides, Cyclic; Prevalence; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2005 |
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Immunosuppressive Agents; Injections; Lung Transplantation; Opportunistic Infections; Pyrimidines; Triazoles; Visual Acuity; Vitrectomy; Vitreous Body; Voriconazole | 2006 |
[Clinical cases in medical mycology. Case no. 21].
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Endophthalmitis; Exophiala; Female; Fungemia; Humans; Itraconazole; Middle Aged; Mycoses; Opportunistic Infections; Osteolysis; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Th2 Cells; Triazoles; Voriconazole | 2006 |
[Successful treatment with voriconazole for disseminated cutaneous and visceral infection by Fusarium solani in a patient with acute myeloid leukemia].
Topics: Antifungal Agents; Dermatomycoses; Fusarium; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
[Successful treatment by voliconazole for pulmonary and adductor magnus muscle aspergillosis induced by immunosuppressive therapy for hypersensitivity pneumonia].
Topics: Aged; Alveolitis, Extrinsic Allergic; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cyclosporine; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases, Fungal; Myositis; Opportunistic Infections; Prednisolone; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Humans; Mucositis; Mycoses; Opportunistic Infections; Oxidoreductases; Point Mutation; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2007 |
Invasive tracheal aspergillosis treated successfully with voriconazole: clinical report and review of the literature.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus flavus; Fatal Outcome; Female; Humans; Laryngoscopy; Leukemia, Myeloid, Acute; Opportunistic Infections; Pyrimidines; Tracheitis; Triazoles; Voriconazole | 2007 |
Voriconazole plasma monitoring.
Topics: Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Drug Monitoring; Humans; Leukemia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2008 |
Non-Candida albicans Candida mediastinitis of odontogenic origin in a diabetic patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Diabetes Mellitus, Type 2; Female; Humans; Mediastinitis; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2008 |
Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia.
Topics: Adolescent; Aspergillosis; Aspergillus fumigatus; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Thyroid Diseases; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2008 |
Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.
Topics: Acute Disease; Adolescent; Antifungal Agents; Aspergillosis; Brain Diseases; Humans; Leukemia; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 1997 |
Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole.
Topics: Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Triazoles; Voriconazole | 2000 |
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2001 |